Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

CSF chitinase proteins in amyotrophic lateral sclerosis.

Thompson AG, Gray E, Bampton A, Raciborska D, Talbot K, Turner MR.

J Neurol Neurosurg Psychiatry. 2019 May 23. pii: jnnp-2019-320442. doi: 10.1136/jnnp-2019-320442. [Epub ahead of print]

PMID:
31123140
2.

MND Plus.

Turner MR.

Pract Neurol. 2019 May 21. pii: practneurol-2019-002213. doi: 10.1136/practneurol-2019-002213. [Epub ahead of print] No abstract available.

PMID:
31113829
3.

Therapeutic non-invasive brain stimulation in amyotrophic lateral sclerosis: rationale, methods and experience.

Edmond EC, Stagg CJ, Turner MR.

J Neurol Neurosurg Psychiatry. 2019 May 9. pii: jnnp-2018-320213. doi: 10.1136/jnnp-2018-320213. [Epub ahead of print] Review.

PMID:
31072957
4.

Defining pre-symptomatic amyotrophic lateral sclerosis.

Benatar M, Turner MR, Wuu J.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Mar 20:1-7. doi: 10.1080/21678421.2019.1587634. [Epub ahead of print]

PMID:
30892087
5.

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.

van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Benatar M, Berry JD, Chio A, Corcia P, Genge A, Gubitz AK, Lomen-Hoerth C, McDermott CJ, Pioro EP, Rosenfeld J, Silani V, Turner MR, Weber M, Brooks BR, Miller RG, Mitsumoto H; Airlie House ALS Clinical Trials Guidelines Group.

Neurology. 2019 Apr 2;92(14):e1610-e1623. doi: 10.1212/WNL.0000000000007242. Epub 2019 Mar 8.

6.

Relative preservation of triceps over biceps strength in upper limb-onset ALS: the 'split elbow'.

Khalaf R, Martin S, Ellis C, Burman R, Sreedharan J, Shaw C, Leigh PN, Turner MR, Al-Chalabi A.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):730-733. doi: 10.1136/jnnp-2018-319894. Epub 2019 Mar 7.

7.

Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis.

Allen SP, Hall B, Castelli LM, Francis L, Woof R, Siskos AP, Kouloura E, Gray E, Thompson AG, Talbot K, Higginbottom A, Myszczynska M, Allen CF, Stopford MJ, Hemingway J, Bauer CS, Webster CP, De Vos KJ, Turner MR, Keun HC, Hautbergue GM, Ferraiuolo L, Shaw PJ.

Brain. 2019 Mar 1;142(3):586-605. doi: 10.1093/brain/awy353.

8.

Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis.

Proudfoot M, Bede P, Turner MR.

Front Neurol. 2019 Jan 8;9:1148. doi: 10.3389/fneur.2018.01148. eCollection 2018. Review.

9.

Cerebellar tract alterations in PLS and ALS.

Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):281-284. doi: 10.1080/21678421.2018.1562554. Epub 2019 Jan 21.

PMID:
30663900
10.

UFLC-Derived CSF Extracellular Vesicle Origin and Proteome.

Thompson AG, Gray E, Mager I, Fischer R, Thézénas ML, Charles PD, Talbot K, El Andaloussi S, Kessler BM, Wood M, Turner MR.

Proteomics. 2018 Dec;18(24):e1800257. doi: 10.1002/pmic.201800257. Epub 2018 Dec 10.

PMID:
30411858
11.

The reunification of amyotrophic lateral sclerosis.

Turner MR.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):122-123. doi: 10.1136/jnnp-2018-319470. Epub 2018 Oct 8. No abstract available.

PMID:
30297521
12.

Frequency and signature of somatic variants in 1461 human brain exomes.

Wei W, Keogh MJ, Aryaman J, Golder Z, Kullar PJ, Wilson I, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Sarraj SA, Morris CM, Ansorge O, Jones NS, Ironside JW, Chinnery PF.

Genet Med. 2019 Apr;21(4):904-912. doi: 10.1038/s41436-018-0274-3. Epub 2018 Sep 14.

13.

Amyotrophic lateral sclerosis: the complex path to precision medicine.

Talbot K, Feneberg E, Scaber J, Thompson AG, Turner MR.

J Neurol. 2018 Oct;265(10):2454-2462. doi: 10.1007/s00415-018-8983-8. Epub 2018 Jul 27.

14.

Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis.

Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1250-1258. doi: 10.1136/jnnp-2018-318625. Epub 2018 Jul 26.

PMID:
30049750
15.

ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function.

de Majo M, Topp SD, Smith BN, Nishimura AL, Chen HJ, Gkazi AS, Miller J, Wong CH, Vance C, Baas F, Ten Asbroek ALMA, Kenna KP, Ticozzi N, Redondo AG, Esteban-Pérez J, Tiloca C, Verde F, Duga S, Morrison KE, Shaw PJ, Kirby J, Turner MR, Talbot K, Hardiman O, Glass JD, de Belleroche J, Gellera C, Ratti A, Al-Chalabi A, Brown RH, Silani V, Landers JE, Shaw CE.

Neurobiol Aging. 2018 Nov;71:266.e1-266.e10. doi: 10.1016/j.neurobiolaging.2018.06.015. Epub 2018 Jun 25.

16.

Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis.

Turner MR.

Biomark Med. 2018 Jul;12(7):693-696. doi: 10.2217/bmm-2018-0149. Epub 2018 Jun 1. No abstract available.

17.

Impaired corticomuscular and interhemispheric cortical beta oscillation coupling in amyotrophic lateral sclerosis.

Proudfoot M, van Ede F, Quinn A, Colclough GL, Wuu J, Talbot K, Benatar M, Woolrich MW, Nobre AC, Turner MR.

Clin Neurophysiol. 2018 Jul;129(7):1479-1489. doi: 10.1016/j.clinph.2018.03.019. Epub 2018 Apr 6.

PMID:
29678369
18.

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis.

Henderson RD, Garton FC, Kiernan MC, Turner MR, Eisen A.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):570-575. doi: 10.1136/jnnp-2017-317245. Epub 2018 Apr 17. No abstract available.

19.

Increased cerebral functional connectivity in ALS: A resting-state magnetoencephalography study.

Proudfoot M, Colclough GL, Quinn A, Wuu J, Talbot K, Benatar M, Nobre AC, Woolrich MW, Turner MR.

Neurology. 2018 Apr 17;90(16):e1418-e1424. doi: 10.1212/WNL.0000000000005333. Epub 2018 Mar 21.

20.

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.

Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Körner S, Ringer TM, Rödiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chiò A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH.

Lancet Neurol. 2018 May;17(5):423-433. doi: 10.1016/S1474-4422(18)30089-9. Epub 2018 Mar 26.

21.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium, Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium, Gitler AD, Harris T, Myers RM; NYGC ALS Consortium, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A; Project MinE ALS Sequencing Consortium, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw CE, Traynor BJ, Landers JE.

Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

22.

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.

Teunissen CE, Otto M, Engelborghs S, Herukka SK, Lehmann S, Lewczuk P, Lleó A, Perret-Liaudet A, Tumani H, Turner MR, Verbeek MM, Wiltfang J, Zetterberg H, Parnetti L, Blennow K.

Alzheimers Res Ther. 2018 Mar 15;10(1):30. doi: 10.1186/s13195-018-0359-x. Review.

23.

Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology.

Pallebage-Gamarallage M, Foxley S, Menke RAL, Huszar IN, Jenkinson M, Tendler BC, Wang C, Jbabdi S, Turner MR, Miller KL, Ansorge O.

BMC Neurosci. 2018 Mar 13;19(1):11. doi: 10.1186/s12868-018-0416-1.

24.

Towards a TDP-43-Based Biomarker for ALS and FTLD.

Feneberg E, Gray E, Ansorge O, Talbot K, Turner MR.

Mol Neurobiol. 2018 Oct;55(10):7789-7801. doi: 10.1007/s12035-018-0947-6. Epub 2018 Feb 19. Review.

25.

Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.

Turner MR, Balu-Iyer SV.

J Pharm Sci. 2018 May;107(5):1247-1260. doi: 10.1016/j.xphs.2018.01.007. Epub 2018 Jan 11. Review.

26.

Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains.

Keogh MJ, Wei W, Aryaman J, Wilson I, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Al Sarraj S, Morris CM, Ansorge O, Pickering-Brown S, Jones N, Ironside JW, Chinnery PF.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):813-816. doi: 10.1136/jnnp-2017-317234. Epub 2018 Jan 13.

27.

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.

Thompson AG, Gray E, Thézénas ML, Charles PD, Evetts S, Hu MT, Talbot K, Fischer R, Kessler BM, Turner MR.

Ann Neurol. 2018 Feb;83(2):258-268. doi: 10.1002/ana.25143. Epub 2018 Feb 9.

PMID:
29331073
28.

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis.

Menke RAL, Proudfoot M, Talbot K, Turner MR.

Neuroimage Clin. 2017 Dec 18;17:953-961. doi: 10.1016/j.nicl.2017.12.025. eCollection 2018.

29.

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.

Feneberg E, Oeckl P, Steinacker P, Verde F, Barro C, Van Damme P, Gray E, Grosskreutz J, Jardel C, Kuhle J, Koerner S, Lamari F, Amador MDM, Mayer B, Morelli C, Muckova P, Petri S, Poesen K, Raaphorst J, Salachas F, Silani V, Stubendorff B, Turner MR, Verbeek MM, Weishaupt JH, Weydt P, Ludolph AC, Otto M.

Neurology. 2018 Jan 2;90(1):e22-e30. doi: 10.1212/WNL.0000000000004761. Epub 2017 Dec 6.

PMID:
29212830
30.

Kinnier Wilson's puzzling features of amyotrophic lateral sclerosis.

Turner MR, Eisen A, Kiernan MC, Ravits J, Swash M.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):657-666. doi: 10.1136/jnnp-2017-317217. Epub 2017 Nov 9. No abstract available.

PMID:
29122933
31.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27. Review.

32.

Non-invasive in vivo neuropathology of the C9orf72-related ALS-FTD syndrome.

Turner MR.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):4-5. doi: 10.1136/jnnp-2017-317010. Epub 2017 Oct 20. No abstract available.

PMID:
29054918
33.

Focal precentral gyrus involvement in osmotic demyelination.

Turner MR, Jacob J, Matthews L, Sheerin F.

Pract Neurol. 2017 Oct;17(5):410-411. doi: 10.1136/practneurol-2017-001682. Epub 2017 Aug 19. No abstract available.

34.

The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.

Martin S, Trevor-Jones E, Khan S, Shaw K, Marchment D, Kulka A, Ellis CE, Burman R, Turner MR, Carroll L, Mursaleen L, Leigh PN, Shaw CE, Pearce N, Stahl D, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):569-575. doi: 10.1080/21678421.2017.1349151. Epub 2017 Jul 18.

35.

Genetic screening in sporadic ALS and FTD.

Turner MR, Al-Chalabi A, Chio A, Hardiman O, Kiernan MC, Rohrer JD, Rowe J, Seeley W, Talbot K.

J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1042-1044. doi: 10.1136/jnnp-2017-315995. Epub 2017 Jun 22.

36.

Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis.

Fabes J, Matthews L, Filippini N, Talbot K, Jenkinson M, Turner MR.

Acad Radiol. 2017 Oct;24(10):1187-1194. doi: 10.1016/j.acra.2017.04.008. Epub 2017 May 29.

37.

Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.

Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, King A, Ticozzi N, Kenna KP, Soragia-Gkazi A, Miller JW, Sato A, Dias DM, Jeon M, Vance C, Wong CH, de Majo M, Kattuah W, Mitchell JC, Scotter EL, Parkin NW, Sapp PC, Nolan M, Nestor PJ, Simpson M, Weale M, Lek M, Baas F, Vianney de Jong JM, Ten Asbroek ALMA, Redondo AG, Esteban-Pérez J, Tiloca C, Verde F, Duga S, Leigh N, Pall H, Morrison KE, Al-Chalabi A, Shaw PJ, Kirby J, Turner MR, Talbot K, Hardiman O, Glass JD, De Belleroche J, Maki M, Moss SE, Miller C, Gellera C, Ratti A, Al-Sarraj S, Brown RH Jr, Silani V, Landers JE, Shaw CE.

Sci Transl Med. 2017 May 3;9(388). pii: eaad9157. doi: 10.1126/scitranslmed.aad9157.

38.

C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.

Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AGL, Varela MA, Sathyaprakash C, Scaber J, Barbagallo P, Vader P, Mäger I, Ezzat K, Turner MR, Ito N, Gasco S, Ohbayashi N, El Andaloussi S, Takeda S, Fukuda M, Talbot K, Wood MJA.

Brain. 2017 Apr 1;140(4):887-897. doi: 10.1093/brain/awx024.

PMID:
28334866
39.

Is cardiovascular fitness a risk factor for ALS?

Turner MR.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):538. doi: 10.1136/jnnp-2017-315606. Epub 2017 Mar 14. No abstract available.

PMID:
28292783
40.

Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.

Wei W, Keogh MJ, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akanbi M, Santibanez-Koref M, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Al Sarraj S, Morris CM, Ansorge O, Pickering-Brown S, Ironside JW, Chinnery PF.

Acta Neuropathol Commun. 2017 Feb 22;5(1):17. doi: 10.1186/s40478-017-0419-7. No abstract available.

41.

Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.

Wei W, Keogh MJ, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akanbi M, Santibanez-Koref M, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Al Sarraj S, Morris CM, Ansorge O, Pickering-Brown S, Ironside JW, Chinnery PF.

Acta Neuropathol Commun. 2017 Feb 2;5(1):13. doi: 10.1186/s40478-016-0404-6. Erratum in: Acta Neuropathol Commun. 2017 Feb 22;5(1):17.

42.

A Meta-analytic Comparison of Face-to-Face and Online Delivery in Ethics Instruction: The Case for a Hybrid Approach.

Todd EM, Watts LL, Mulhearn TJ, Torrence BS, Turner MR, Connelly S, Mumford MD.

Sci Eng Ethics. 2017 Dec;23(6):1719-1754. doi: 10.1007/s11948-017-9869-3. Epub 2017 Feb 1.

PMID:
28150177
43.

A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS.

Thompson AG, Blackwell V, Marsden R, Millard E, Lawson C, Nickol AH, East JE, Talbot K, Allan PJ, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):243-248. doi: 10.1080/21678421.2016.1274330. Epub 2017 Jan 19.

44.

Sweet food preference in amyotrophic lateral sclerosis.

Turner MR, Talbot K.

Pract Neurol. 2017 Apr;17(2):128-129. doi: 10.1136/practneurol-2016-001554. Epub 2017 Jan 10. No abstract available.

45.

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, HortobáGyi T, Rosenfeld J, Silani V, Ince PG, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174. doi: 10.1080/21678421.2016.1267768. Epub 2017 Jan 5. Review.

PMID:
28054827
46.

Curricular Approaches in Research Ethics Education: Reflecting on More and Less Effective Practices in Instructional Content.

Torrence BS, Watts LL, Mulhearn TJ, Turner MR, Todd EM, Mumford MD, Connelly S.

Account Res. 2017;24(5):269-296. doi: 10.1080/08989621.2016.1276452. Epub 2017 Jan 3.

PMID:
28045558
47.

Cross-Field Comparison of Ethics Education: Golden Rules and Particulars.

Mulhearn TJ, Watts LL, Torrence BS, Todd EM, Turner MR, Connelly S, Mumford MD.

Account Res. 2017;24(4):211-224. doi: 10.1080/08989621.2016.1274974. Epub 2016 Dec 22.

PMID:
28005391
48.

Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.

Keogh MJ, Wei W, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akanbi M, Santibanez-Koref M, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Al Sarraj S, Morris CM, Ansorge O, Pickering-Brown S, Ironside JW, Chinnery PF.

Genome Res. 2017 Jan;27(1):165-173. doi: 10.1101/gr.210609.116. Epub 2016 Dec 21.

49.

The tough body at the epicentre of amyotrophic lateral sclerosis.

Turner MR, Menke RAL.

J Neurol Neurosurg Psychiatry. 2017 May;88(5):369-370. doi: 10.1136/jnnp-2016-315247. Epub 2016 Dec 13. No abstract available.

PMID:
27965396
50.

Motor neuron disease: biomarker development for an expanding cerebral syndrome.

Turner MR.

Clin Med (Lond). 2016 Dec;16(Suppl 6):s60-s65. Review.

Supplemental Content

Loading ...
Support Center